CIK 0001854270 · <br>Emerging growth company
Senti Biosciences Holdings, Inc.
Sign in to watch- Ticker
- SNTI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 862437900
- Phone
- (650) 239-2030
- Business address
- 2 CORPORATE DRIVE, FIRST FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Senti Biosciences, Inc., Senti Biosciences, Inc.\, Dynamics Special Purpose Corp.
- 8-K Event Material agreement · Regulation FD disclosure
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- DEFM14A Deal DEFM14A
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- UPLOAD Other SEC-generated Letter
- SC 13G/A Stake Amended Statement of Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- UPLOAD Other SEC-generated Letter
- 10-K Report Annual Report
Page 16 of 19 · 368 filings